Thr92Ala-DIO2 heterozygosity is associated with skeletal muscle mass and myosteatosis in patients with COVID-19

Thr92Ala-DIO2 heterozygosity is associated with skeletal muscle mass and myosteatosis in patients with COVID-19

Introduction: The type 2 deiodinase and its Thr92Ala-DIO2 polymorphism have been linked to clinical outcomes in acute lung injury and coronavirus disease 2019 (COVID-19). Objective: The objective was to identify a potential association between Thr92Ala-DIO2 polymorphism and body composition (appen...

Full description

Bibliographic Details
Main Authors: Fabyan Esberard de Lima Beltrão, Daniele Carvalhal de Almeida Beltrão, Giulia Carvalhal, Fabyanna Lethicia de Lima Beltrão, Jocyel de Brito Oliveira, Hatilla dos Santos Silva, Helena Mariana Pitangueira Teixeira, Juliana Lopes Rodrigues, Camila Alexandrina Viana de Figueiredo, Ryan dos Santos Costa, Fabio Hecht, Giciane Carvalho Vieira, Maria da Conceição Rodrigues Gonçalves, Antonio C. Bianco, Helton Estrela Ramos
Format: Article
Language:English
Published: Bioscientifica 2024-08-01
Series:European Thyroid Journal
Subjects:
covid-19; muscle
myosteatosis
thr92ala-dio2
Online Access:https://etj.bioscientifica.com/view/journals/etj/13/4/ETJ-24-0068.xml

Internet

https://etj.bioscientifica.com/view/journals/etj/13/4/ETJ-24-0068.xml

Similar Items